The FDA just approved the first GLP-1 weight-loss pill. Here’s what to know.
Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly. View original article Contributor: Daniel Gilbert
Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly. View original article Contributor: Daniel Gilbert
Complementary and Alternative Medicine for Anti Aging & Longetivity Market Size, Share Market.us >View original article Contributor:
Considering an ‘Alternative’ Health Care Plan? Here’s What You Need to Know mb.ntd.com >View original article Contributor:
Consumers are left with few options and crushing prices as insurers offering Affordable Care Act plans pull out of some regions. View original article Contributor: Peter Whoriskey
Baby boomers and Gen Xers are taking steps to ensure their children aren’t left with the financial and emotional toll of caretaking. View original article Contributor: Shannon Najmabadi
In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side effects. View original article Contributor: Paula Span
‘A potential treasure trove’: World Health Organization to explore benefits of traditional medicines The Guardian >View original article Contributor:
Hungarian Researchers Develop First Hungarian Adaptation of I-CAM-Q to Study Complementary and Alternative Medicine Usage geneonline.com >View original article Contributor:
Hungarian Adaptation of I-CAM-Q for CAM Assessment BIOENGINEER.ORG >View original article Contributor:
The plan, which is not finalized, suggests children get fewer shots and shifts to a model telling parents to consult doctors to make their own vaccine choices. View original article Contributor: Lena H. Sun, Rachel Roubein